MENU
RNLXY
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Renalytix (RNLXY) Ownership - Who owns Renalytix?
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally... Show more
Details
Group
Domestic Stock Funds
Category
Health Services
Capitalization
25.87M
P/E Ratio
N/A
Total Cash
909K
Projected Growth
N/A
Total Debt
8.25M
Revenue
2.35M
Risk (Beta)
2.53
Dividend Yield
N/A
Total Cash/Share
0.01
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
RNLXY
Capitalization
25.9M
P/E Ratio
N/A
Risk (Beta)
2.53
Dividend Yield
N/A
Total Cash
909K
Total Cash/Share
0.01
Total Debt
8.25M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
2.35M
ROE
N/A
Book Value
-11.32M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.48
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
515K
Current Ratio
0.24
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-23.79M
Float
N/A
Float - Current
N/A
Gross Income Margin
19.16
Revenue To Assets
-230.38
Shares Held By Institutions
1.08M
Shares Outstanding - Current
166M
Total Liabilities
16.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-33.349
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RNLXY showed earnings on March 18, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information